The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Series D | Alive

Total Raised

$9.2M

Last Raised

$2.2M | 22 yrs ago

About Nephros

Nephros is a New York, New York-based Healthcare company.

Nephros Headquarter Location

New York, New York, 10025,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Nephros Patents

Nephros has filed 13 patents.

The 3 most popular patent topics include:

  • Membrane technology
  • Binary stars
  • Brown dwarfs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/3/2018

11/3/2020

Membrane technology, Renal dialysis, Nephrology, Fluid dynamics, Hepatology

Grant

Application Date

7/3/2018

Grant Date

11/3/2020

Title

Related Topics

Membrane technology, Renal dialysis, Nephrology, Fluid dynamics, Hepatology

Status

Grant

Latest Nephros News

Earnings Outlook For Nephros

May 3, 2022

Nephros (NASDAQ:NEPH) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Nephros will report an earnings per share (EPS) of $-0.11. read more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.